The Saudi Food and Drug Authority has approved Unibio’s microbial single-cell protein (SCP), Uniprotein®, for use in aquaculture for fish and crustaceans. With this approval, Uniprotein® is cleared for sale to the Saudi feed industry and can be tested in commercial conditions.
Unibio’s microbial single-cell protein, Uniprotein®, has been officially approved for use in aquaculture for fish and crustaceans by the Saudi Food and Drug Authority (SFDA). Following a comprehensive review process that began in April 2023, the SFDA has confirmed the safety of Uniprotein® for use in feed for fish and shrimp. With this approval, Uniprotein® is now cleared for sale to the Saudi feed industry and can be tested in commercial conditions, reinforcing the significant benefits of microbial single-cell protein.
A SUSTAINABLE PROTEIN ALTERNATIVE
The company describes Uniprotein® as a high-quality, sustainable protein that serves as a viable alternative to traditional protein sources such as fishmeal and soy. Its amino acid profile closely mirrors that of fishmeal, and it has already been approved for use in feed for both terrestrial and aquatic animals in the European Union. Global approvals are ongoing, Unibio states.
Uniprotein® stands out for its consistent quality, being free of pesticides and antibiotic, full traceability, and non-GMO status, the company points out. The product has generated strong interest from customers around the world and is currently under development for potential direct human consumption.
A STRATEGIC MOVE INTO THE MIDDLE EAST
“We are pleased to announce that Uniprotein® has been approved for aquaculture applications in the Kingdom of Saudi Arabia (KSA). This is a significant step into KSA, a key region that is working towards feed and food self-sufficiency under the Vision 2030 program, while increasing local fish production,” said Olivier Hartz, CCO at Unibio.
